Ikarian Capital, LLC Shattuck Labs, Inc. Transaction History

Ikarian Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.36 - $21.08 $302,966 - $763,939	-36,240 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.57 - $28.95 $2.71 Million - $4.46 Million	-154,090 Reduced 80.96%	36,240 $739,000
Q1 2021 May 17, 2021	BUY	$27.92 - $52.5 $3.5 Million - $6.58 Million	125,330 Added 192.82%	190,330 $5.57 Million
Q4 2020 Feb 12, 2021	BUY	$19.0 - $57.61 $1.24 Million - $3.74 Million	65,000 New	65,000 $3.41 Million

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $47M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.